P2.13-16 Preference of Adjuvant Treatments for EGFR-Mutant Resected NSCLC Patients: Results of a National-Wide Survey in China
Autor: | Guo, M., Huang, W., Zhao, Y., Liang, W., He, J. |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2018 13(10) Supplement:S804-S804 |
Databáze: | ScienceDirect |
Externí odkaz: |